IMR Press / FBL / Volume 22 / Issue 10 / DOI: 10.2741/4569

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Review

Targeted radionuclide therapy: frontiers in theranostics

Show Less
1 Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan, Italy
2 Instituto de Fisica E. Gaviola, CONICET, Argentina
3 Laboratory for Research and Instrumentation in Physics Applied to Medicine and X-Ray Imaging (LIIFAMIRx), National University of Cordoba, Cordoba, Argentina
4 Centro de Fisica e Ingenieriía en Medicina, CFIM, Universidad de La Frontera, Temuco, Chile
5 Departamento de Ciencias Fisicas, Universidad de La Frontera, Temuco, Chile
6 Department of Nuclear Medicine, Centre for Experimental Imaging, San Raffaele Scientific Institute, Milan, Italy

Academic Editors: Isabella Castiglioni, Gloria Bertoli, Claudia Cava

Front. Biosci. (Landmark Ed) 2017, 22(10), 1750–1759;
Published: 1 March 2017
(This article belongs to the Special Issue Frontiers in biomarker for theranostics)

The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear medicine as treating agents, targeted at the cellular or molecular level. The growth of the interest in TRT was stimulated by the advances in radionuclide production and labeling as well as by the improvement in the knowledge of appropriate and specific molecular targets. In recent years, different studies on TRT were focused on the evaluation of radionuclide compounds able to combine imaging of the disease with TRT, in a theranostic approach. This approach is of particular interest towards the personalization of treatments, allowing both the baseline characterization of oncological pathologies and treatment optimization by correct dosimetric calculation as well as therapy monitoring. This paper presents a review of recent literature on TRT, with a particular focus on clinical applications promoting such a theranostic approach, showing the impact of the synergy of diagnostic imaging and therapeutics.

Radionuclide therapy
Back to top